Newsroom

Sorted by: Latest

-

North America Upstream Development (Excluding the US L48) Industry Outlook Report 2025: Production to Increase by 2030, Driven by Canada's Undeveloped Reserves, Advancing Technologies, and Investments - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Upstream Development Outlook, 2025-2030 (Excluding the US L48)" report has been added to ResearchAndMarkets.com's offering. The North America region, comprising the US, Canada, Mexico, and Greenland, plays a pivotal part of the global oil and gas landscape, as it holds sizeable oil and gas reserves and is a leading producer, exporter, and innovator in upstream technologies. The overall production in the region (excluding the US L48) is likely to incre...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 22.12.2025 FEUZ IE00B8X9NY41 1,103,799.00 EUR 62,821,207.63 56.914  ...
-

Mastercard SpendingPulse: Savvy Shoppers and E-Commerce Fuel U.S. Holiday Retail Sales Growth by 3.9% YOY

PURCHASE, N.Y.--(BUSINESS WIRE)--According to preliminary insights from Mastercard SpendingPulse™, U.S. retail sales excluding automotive increased 3.9% year-over-year from November 1 through December 21. Mastercard SpendingPulse measures in-store and online retail sales representing all payment types and is not adjusted for inflation. “Consumers demonstrated flexibility and confidence this season, shopping early, leveraging promotions, and investing in meaningful experiences and wish-list item...
-

VSE Corporation Completes Aero 3 Acquisition

MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that the Company has closed its previously announced acquisition of GenNx/AeroRepair IntermediateCo Inc., the parent company of Aero 3, Inc. (“Aero 3”), a portfolio company of GenNx360 Capital Partners. Aero 3 is a diversified global Maintenance, Repair and Overhaul (MRO) service provider and distributor supporting...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 22.12.2025 LANDXEN.LN IE000C75IMX8 22,412.00 USD 414,158.45 18.479  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 22.12.2025 GRDU.LN IE000J80JTL1 20,750,002.00 USD 1,104,033,961.59 53.206  ...
-

American Heart Association (AHA) Scientific Sessions Highlights Report 2025: Indications, Companies, and Therapies Focus on GLP-1RAs, Hyperlipidemia, Heart Failure, Pulmonary Arterial Hypertension - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "American Heart Association (AHA): Scientific Sessions 2025 Highlights" report has been added to ResearchAndMarkets.com's offering. AHA 2025 took place in New Orleans, Louisiana, between 7-10 November 2025. The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine. Th...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 22.12.2025 LANDXN.LN IE000RN036E0 28,035.00 USD 564,171.60 20.124  ...
-

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) approved the New Drug Application (NDA) for COBENFY® (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. COBENFY is the first schizophrenia therapy with a novel mechanism of action approved in over 70 years [1], offering a fundamentally new approach to treating schizophrenia. By selectively activating M...
-

Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Obesity KOL Webinar – ARO-INHBE and ARO-ALK7 Interim Clinical Data – January 6, 2026 Type: Company KOL Webinar Date/Time: January 6, 2026, 11:30 a.m. EST J.P. Morgan 2026 Healthcare Conference – January 12-15, 2026 Type: Corporate Presentation Date/Time: January 12, 2026, 10:30 a.m. EST Presentation materials and webcast links, i...